BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10440436)

  • 41. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media.
    Gooch WM; Blair E; Puopolo A; Paster RZ; Schwartz RH; Miller HC; Smyre HL; Yetman R; Giguere GG; Collins JJ
    Pediatr Infect Dis J; 1996 Feb; 15(2):157-64. PubMed ID: 8822290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized, multicentre, comparative clinical evaluation of cefuroxime-sulbactam versus amoxicillin-clavulanic acid therapy in the treatment of lower respiratory tract infections.
    Pareek A; Pednekar S; Prasad HB; Salagre S; Chandurkar N
    J Int Med Res; 2008; 36(6):1293-304. PubMed ID: 19094439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The efficacy of the combined preparation ampicillin/sulbactam (Unasyn) in treating postoperative suppurative complications in a surgical hospital].
    Ginters Ia; Ginters G; Leĭtans G
    Antibiot Khimioter; 1991 Jun; 36(6):11-2. PubMed ID: 1898181
    [No Abstract]   [Full Text] [Related]  

  • 44. Rational antibiotic therapy and the position of ampicillin/sulbactam.
    Lode HM
    Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ampicillin/sulbactam vs. clindamycin/gentamicin in the treatment of postpartum endometritis.
    Gall S; Koukol DH
    J Reprod Med; 1996 Aug; 41(8):575-80. PubMed ID: 8866384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experiences with sultamicillin granules in pediatric patients].
    Iguchi K; Kamiya H; Sakurai M; Shimizu S; Nishi H; Kawaguchi H; Yoshizumi T; Inoue M; Kojima M
    Jpn J Antibiot; 1988 Dec; 41(12):1906-13. PubMed ID: 3249363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical studies on sulbactam/ampicillin in the field of pediatrics].
    Iwata S; Yamada K; Sato Y; Ishikawa K; Akita H; Sunakawa K
    Jpn J Antibiot; 1989 Mar; 42(3):598-611. PubMed ID: 2664249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sulbactam-ampicillin in surgery. Our experience].
    Germiniani R; Casiraghi S; Pace M; Caspani P; Trabucchi E
    Minerva Chir; 1992 Oct; 47(20):1627-9. PubMed ID: 1480290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical evaluation of sulbactam/ampicillin in the pediatric infections].
    Meguro H; Arimasu O; Shiraishi H; Sugamata K; Hiruma F; Abe T; Fujii R; Mashiko J; Nagao Y; Okamoto Y
    Jpn J Antibiot; 1989 Mar; 42(3):612-22. PubMed ID: 2746845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial.
    Güneren MF
    Drugs; 1988; 35 Suppl 7():57-68. PubMed ID: 3065055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Friedel HA; Campoli-Richards DM; Goa KL
    Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ampicillin-sulbactam monotherapy in infants with febrile urinary tract infections.
    Song JY; Yoo S; Lim TJ; Byun JH; Jo KJ; Kim HY; Park SE; Kim SH
    Pediatr Int; 2021 Apr; 63(4):430-435. PubMed ID: 32885532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The clinical diagnosis and treatment of ascending infections of the genitalia by using the combined preparation ampicillin/sulbactam (Unasyn)].
    Eibach HW
    Antibiot Khimioter; 1991 Jun; 36(6):13-5. PubMed ID: 1832852
    [No Abstract]   [Full Text] [Related]  

  • 54. An open non-comparative pilot study of the safety and efficacy of oral sultamicillin in the treatment of mild to moderate upper respiratory tract infections in children.
    Argüello A
    J Int Med Res; 1992; 20 Suppl 1():24A-30A. PubMed ID: 1451926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin.
    Hemsell DL; Bawdon RE; Hemsell PG; Nobles BJ; Heard MC
    J Int Med Res; 1990; 18 Suppl 4():85D-89D. PubMed ID: 2282973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ampicillin/sulbactam: current status in severe bacterial infections.
    Rafailidis PI; Ioannidou EN; Falagas ME
    Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An open comparative study of the efficacy and safety of sultamicillin versus cefaclor in the treatment of acute otitis media in children.
    Biolcati AH
    J Int Med Res; 1992; 20 Suppl 1():31A-43A. PubMed ID: 1451927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly.
    Okimoto N; Kurihara T; Honda N; Asaoka N; Fujita K; Ohba H; Nakamura J
    J Infect Chemother; 2003 Jun; 9(2):183-6. PubMed ID: 12825120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis.
    McGregor JA; Crombleholme WR; Newton E; Sweet RL; Tuomala R; Gibbs RS
    Obstet Gynecol; 1994 Jun; 83(6):998-1004. PubMed ID: 8190448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease.
    Gunning J
    Drugs; 1986; 31 Suppl 2():14-7. PubMed ID: 3013567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.